Kristian T. Hansen

GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand

Linda Yang, Chih-Chuan Chang, Zhe Sun et al. · Nature Medicine · 2017 · 652 citations

Life Sciences, Biochemistry, Endocrinology +8

CYP2C8 and CYP3A4 are the principal enzymes involved in the human <i>in vitro</i> biotransformation of the insulin secretagogue repaglinide

Tanja Busk Bidstrup, Inga Bjørnsdottir, Ulla G. Sidelmann et al. · British Journal of Clinical Pharmacology · 2003 · 203 citations · Full text

Medicine, Biochemistry, Pharmacology +17

PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor

Per Karlsson, Lars Farde, Christer Halldin et al. · Psychopharmacology · 1993 · 130 citations · Full text

Medicine, Neuroscience, Pharmacology +15

Influence of Drugs Interacting with CYP3A4 on the Pharmacokinetics, Pharmacodynamics, and Safety of the Prandial Glucose Regulator Repaglinide

Vibeke Hatorp, Kristian T. Hansen, Mikael S. Thomsen · The Journal of Clinical Pharmacology · 2003 · 106 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

Xanomeline: A selective muscarinic agonist for the treatment of Alzheimer's disease

Frank P. Bymaster, Celia A. Whitesitt, Harlan E. Shannon et al. · Drug Development Research · 1997 · 105 citations

Medicine, Neuroscience, Pharmacology +17